Levosimendan in Cardiac Surgery: Evaluating the Evidence

Shaji A. Faisal, David A. Apatov, Harish Ramakrishna, Menachem M. Weiner

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Abstract

Levosimendan, a calcium-sensitizing and Adenosine triphosphate-sensitive potassium channel opening inodilator, has the potential to improve cardiac function without increasing oxygen consumption. The evidence supporting the use of levosimendan in the cardiac surgical perioperative period is not well-established. Recently, large-scale randomized controlled trials studying the utility of levosimendan in cardiac surgery have been conducted. This review examines the physiological and pharmacologic properties of levosimendan and evaluates the literature regarding the use of levosimendan in patients undergoing cardiac surgery.

Original languageEnglish
Pages (from-to)1146-1158
Number of pages13
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume33
Issue number4
DOIs
StatePublished - Apr 2019

Keywords

  • cardiac surgery
  • inotropes
  • levosimendan
  • low cardiac output syndrome

Fingerprint

Dive into the research topics of 'Levosimendan in Cardiac Surgery: Evaluating the Evidence'. Together they form a unique fingerprint.

Cite this